Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 40
Filter
Add more filters










Publication year range
1.
Gene Ther ; 24(12): 787-800, 2017 12.
Article in English | MEDLINE | ID: mdl-28872643

ABSTRACT

There is much debate on the adeno-associated virus (AAV) serotype that best targets specific retinal cell types and the route of surgical delivery-intravitreal or subretinal. This study compared three of the most efficacious AAV vectors known to date in a mouse model of retinal degeneration (rd1 mouse) and macaque and human retinal explants. Green fluorescent protein (GFP) driven by a ubiquitous promoter was packaged into three AAV capsids: AAV2/8(Y733F), AAV2/2(quad Y-F) and AAV2/2(7m8). Overall, AAV2/2(7m8) transduced the largest area of retina and resulted in the highest level of GFP expression, followed by AAV2/2(quad Y-F) and AAV2/8(Y733F). AAV2/2(7m8) and AAV2/2(quad Y-F) both resulted in similar patterns of transduction whether they were injected intravitreally or subretinally. AAV2/8(Y733F) transduced a significantly smaller area of retina when injected intravitreally compared with subretinally. Retinal ganglion cells, horizontal cells and retinal pigment epithelium expressed relatively high levels of GFP in the mouse retina, whereas amacrine cells expressed low levels of GFP and bipolar cells were infrequently transduced. Cone cells were the most frequently transduced cell type in macaque retina explants, whereas Müller cells were the predominant transduced cell type in human retinal explants. Of the AAV serotypes tested, AAV2/2(7m8) was the most effective at transducing a range of cell types in degenerate mouse retina and macaque and human retinal explants.


Subject(s)
Dependovirus/genetics , Recombination, Genetic , Retina/metabolism , Viral Tropism/genetics , Animals , Disease Models, Animal , Genetic Vectors , Humans , Intravitreal Injections , Macaca , Mice , Promoter Regions, Genetic , Retina/cytology , Retina/virology , Retinal Degeneration/genetics , Retinal Ganglion Cells/metabolism , Retinal Pigment Epithelium/metabolism , Virus Assembly
2.
Gene Ther ; 22(2): 116-26, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25503696

ABSTRACT

Gene delivery vectors based on adeno-associated viruses (AAV) have exhibited promise in both preclinical disease models and human clinical trials for numerous disease targets, including the retinal degenerative disorders Leber's congenital amaurosis and choroideremia. One general challenge for AAV is that preexisting immunity, as well as subsequent development of immunity following vector administration, can severely inhibit systemic AAV vector gene delivery. However, the role of neutralizing antibodies (NABs) in AAV transduction of tissues considered to be immune privileged, such as the eye, is unclear in large animals. Intravitreal AAV administration allows for broad retinal delivery, but is more susceptible to interactions with the immune system than subretinal administration. To assess the effects of systemic anti-AAV antibody levels on intravitreal gene delivery, we quantified the anti-AAV antibodies present in sera from non-human primates before and after intravitreal injections with various AAV capsids. Analysis showed that intravitreal administration resulted in an increase in anti-AAV antibodies regardless of the capsid serotype, transgene or dosage of virus injected. For monkeys injected with wild-type AAV2 and/or an AAV2 mutant, the variable that most significantly affected the production of anti-AAV2 antibodies was the amount of virus delivered. In addition, post-injection antibody titers were highest against the serotype administered, but the antibodies were also cross-reactive against other AAV serotypes. Furthermore, NAB levels in serum correlated with those in vitreal fluid, demonstrating both that this route of administration exposes AAV capsid epitopes to the adaptive immune system and that serum measurements are predictive of vitreous fluid NAB titers. Moreover, the presence of preexisting NAB titers in the serum of monkeys correlated strongly (R=0.76) with weak, decaying or no transgene expression following intravitreal administration of AAV. Investigating anti-AAV antibody development will aid in understanding the interactions between gene therapy vectors and the immune system during ocular administration and can form a basis for future clinical studies applying intravitreal gene delivery.


Subject(s)
Antibodies, Neutralizing/physiology , Antibodies, Viral/physiology , Dependovirus/immunology , Retinal Degeneration/therapy , Animals , Dependovirus/genetics , Genetic Therapy , Genetic Vectors , HEK293 Cells , Humans , Intravitreal Injections , Macaca mulatta , Transduction, Genetic
3.
Gene Ther ; 21(6): 585-92, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24694538

ABSTRACT

X-linked retinoschisis, a disease characterized by splitting of the retina, is caused by mutations in the retinoschisin gene, which encodes a putative secreted cell adhesion protein. Currently, there is no effective treatment for retinoschisis, though viral vector-mediated gene replacement therapies offer promise. We used intravitreal delivery of three different AAV vectors to target delivery of the RS1 gene to Müller glia, photoreceptors or multiple cell types throughout the retina. Müller glia radially span the entire retina, are accessible from the vitreous, and remain intact throughout progression of the disease. However, photoreceptors, not glia, normally secrete retinoschisin. We compared the efficacy of rescue mediated by retinoschisin secretion from these specific subtypes of retinal cells in the Rs1h-/- mouse model of retinoschisis. Our results indicate that all three vectors deliver the RS1 gene, and that several cell types can secrete retinoschisin, leading to transport of the protein across the retina. The greatest long-term rescue was observed when photoreceptors produce retinoschisin. Similar rescue was observed with photoreceptor-specific or generalized expression, although photoreceptor secretion may contribute to rescue in the latter case. These results collectively point to the importance of cell targeting and appropriate vector choice in the success of retinal gene therapies.


Subject(s)
Eye Proteins/genetics , Genetic Therapy/methods , Retina/cytology , Aging , Animals , Cell Adhesion Molecules/genetics , Disease Models, Animal , Electroretinography , Genetic Vectors/genetics , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Humans , Mice, Inbred C57BL , Mice, Mutant Strains , Organ Culture Techniques , Photoreceptor Cells, Vertebrate/physiology , Retina/physiology , Retinoschisis/genetics , Retinoschisis/therapy
4.
Cell Death Dis ; 4: e734, 2013 Jul 18.
Article in English | MEDLINE | ID: mdl-23868067

ABSTRACT

The use of the visual system played a major role in the elucidation of molecular mechanisms controlling axonal regeneration in the injured CNS after trauma. In this model, CNTF was shown to be the most potent known neurotrophic factor for axonal regeneration in the injured optic nerve. To clarify the role of the downstream growth regulator Stat3, we analyzed axonal regeneration and neuronal survival after an optic nerve crush in adult mice. The infection of retinal ganglion cells with adeno-associated virus serotype 2 (AAV2) containing wild-type (Stat3-wt) or constitutively active (Stat3-ca) Stat3 cDNA promoted axonal regeneration in the injured optic nerve. Axonal growth was analyzed in whole-mounted optic nerves in three dimensions (3D) after tissue clearing. Surprisingly, with AAV2.Stat3-ca stimulation, axons elongating beyond the lesion site displayed very irregular courses, including frequent U-turns, suggesting massive directionality and guidance problems. The pharmacological blockade of ROCK, a key signaling component for myelin-associated growth inhibitors, reduced axonal U-turns and potentiated AAV2.Stat3-ca-induced regeneration. Similar results were obtained after the sustained delivery of CNTF in the axotomized retina. These results show the important role of Stat3 in the activation of the neuronal growth program for regeneration, and they reveal that axonal misguidance is a key limiting factor that can affect long-distance regeneration and target interaction after trauma in the CNS. The correction of axonal misguidance was associated with improved long-distance axon regeneration in the injured adult CNS.


Subject(s)
Axons/physiology , Nerve Regeneration , Optic Nerve/physiology , STAT3 Transcription Factor/genetics , Signal Transduction , Amides/pharmacology , Animals , Aporphines , Cell Survival , Ciliary Neurotrophic Factor/physiology , Dependovirus/genetics , Male , Mice , Mice, Inbred C57BL , Optic Nerve/cytology , Pyridines/pharmacology , Retinal Ganglion Cells/physiology , STAT3 Transcription Factor/metabolism , STAT3 Transcription Factor/physiology , Transcription, Genetic , Transduction, Genetic , rho GTP-Binding Proteins/antagonists & inhibitors , rho GTP-Binding Proteins/metabolism , rho-Associated Kinases/metabolism
5.
Gene Ther ; 19(2): 176-81, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22011645

ABSTRACT

Delivery of therapeutic genes to a large region of the retina with minimal damage from intraocular surgery is a central goal of treatment for retinal degenerations. Recent studies have shown that AAV9 can reach the central nervous system (CNS) and retina when administered systemically to neonates, which is a promising strategy for some retinal diseases. We investigated whether the retinal transduction efficiency of systemically delivered AAV9 could be improved by mutating capsid surface tyrosines, previously shown to increase the infectivity of several AAV vectors. Specifically, we evaluated retinal transduction following neonatal intravascular administration of AAV9 vectors containing tyrosine to phenylalanine mutations at two highly conserved sites. Our results show that a novel, double tyrosine mutant of AAV9 significantly enhanced gene delivery to the CNS and retina, and that gene expression can be restricted to rod photoreceptor cells by incorporating a rhodopsin promoter. This approach provides a new methodology for the development of retinal gene therapies or creation of animal models of neurodegenerative disease.


Subject(s)
Central Nervous System , Dependovirus/genetics , Genetic Therapy , Retina/pathology , Retinal Degeneration/therapy , Animals , Disease Models, Animal , Gene Expression Regulation, Developmental , Genetic Vectors/administration & dosage , Green Fluorescent Proteins , Humans , Mice , Mice, Inbred C57BL , Mutation , Promoter Regions, Genetic , Retina/cytology , Retina/growth & development , Retinal Degeneration/genetics , Retinal Rod Photoreceptor Cells/metabolism , Rhodopsin/genetics
6.
Cell Death Differ ; 19(7): 1096-108, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22193546

ABSTRACT

Nogo-A, an axonal growth inhibitory protein known to be mostly present in CNS myelin, was upregulated in retinal ganglion cells (RGCs) after optic nerve injury in adult mice. Nogo-A increased concomitantly with the endoplasmic reticulum stress (ER stress) marker C/EBP homologous protein (CHOP), but CHOP immunostaining and the apoptosis marker annexin V did not co-localize with Nogo-A in individual RGC cell bodies, suggesting that injury-induced Nogo-A upregulation is not involved in axotomy-induced cell death. Silencing Nogo-A with an adeno-associated virus serotype 2 containing a short hairpin RNA (AAV2.shRNA-Nogo-A) or Nogo-A gene ablation in knock-out (KO) animals had little effect on the lesion-induced cell stress or death. On the other hand, Nogo-A overexpression mediated by AAV2.Nogo-A exacerbated RGC cell death after injury. Strikingly, however, injury-induced sprouting of the cut axons and the expression of growth-associated molecules were markedly reduced by AAV2.shRNA-Nogo-A. The axonal growth in the optic nerve activated by the intraocular injection of the inflammatory molecule Pam3Cys tended to be lower in Nogo-A KO mice than in WT mice. Nogo-A overexpression in RGCs in vivo or in the neuronal cell line F11 in vitro promoted regeneration, demonstrating a positive, cell-autonomous role for neuronal Nogo-A in the modulation of axonal regeneration.


Subject(s)
Apoptosis/drug effects , Endoplasmic Reticulum Stress , Myelin Proteins/metabolism , Neurons/metabolism , Retina/cytology , Up-Regulation , Animals , Annexin A5/metabolism , Axotomy , Cells, Cultured , Dependovirus/genetics , Lipoproteins/pharmacology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Myelin Proteins/antagonists & inhibitors , Myelin Proteins/genetics , Neurites/physiology , Nogo Proteins , RNA Interference , RNA, Small Interfering/metabolism , Regeneration/drug effects , Retina/metabolism , Retinal Ganglion Cells/cytology , Retinal Ganglion Cells/metabolism , Transcription Factor CHOP/genetics , Transcription Factor CHOP/metabolism
7.
Mol Ther ; 4(6): 622-9, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11735347

ABSTRACT

We designed experiments to evaluate the therapeutic potential of glial cell line derived neurotrophic factor (GDNF) to rescue photoreceptors from genetically determined cell death. Gene transfer of the neurotrophic factor to the retina was achieved via a recombinant adeno-associated virus (rAAV) vector containing the chicken beta-actin promoter/immediate early cytomegalovirus enhancer (CBA) driving the human GDNF gene. We delivered AAV-CBA-GDNF to the retinas of an animal model of retinitis pigmentosa, the TgN S334ter-4 rhodopsin line of transgenic rats. Immunohistochemical studies localized AAV-CBA-GDNF-derived recombinant protein to cell bodies, inner segments, and outer segments of photoreceptor cells as well as to retinal pigment epithelial cells. We assessed the effect of viral delivery by morphometric and electroretinographic analysis. These experiments showed that GDNF vector treatment leads to increased rod photoreceptor survival as indicated by morphometric analysis of outer nuclear layer thickness. AAV-CBA-GDNF-treated retinas also demonstrated functional improvement by the substantially increased amplitude of electroretinograms. AAV-CBA-GDNF delivery had a significant rescue effect on photoreceptor degeneration in this animal model.


Subject(s)
Dependovirus/genetics , Genetic Therapy , Nerve Growth Factors , Nerve Tissue Proteins/genetics , Retinitis Pigmentosa/therapy , Actins/genetics , Animals , Animals, Genetically Modified , Blotting, Western , DNA Primers/chemistry , Electroretinography , Genes, Reporter , Genetic Vectors , Glial Cell Line-Derived Neurotrophic Factor , Green Fluorescent Proteins , Immunoenzyme Techniques , Luminescent Proteins/metabolism , Models, Animal , Nerve Tissue Proteins/biosynthesis , Photoreceptor Cells/physiology , Promoter Regions, Genetic , Rats , Rats, Sprague-Dawley , Recombinant Fusion Proteins/metabolism , Retinitis Pigmentosa/metabolism , Retinitis Pigmentosa/physiopathology , Reverse Transcriptase Polymerase Chain Reaction
8.
Mol Ther ; 3(5 Pt 1): 688-96, 2001 May.
Article in English | MEDLINE | ID: mdl-11356074

ABSTRACT

Viral delivery of neurotrophins or other therapeutic genes is an attractive option for treating retinal degeneration. Regulated expression of these genes in the retina is needed to aid in dose delivery and to promote safety. To evaluate whether tetracycline (tet)-inducible transgenes encapsidated in recombinant adeno-associated viruses (rAAV) can provide controlled gene expression in vitro and in the rat retina, two viruses were constructed: a silencer/activator vector and an inducible doxycycline (dox)-responsive GFP vector. Combinations of these two viruses were subretinally injected into wild-type rats and dox was orally administered through the drinking water. Retinal GFP expression was monitored in vivo with a noninvasive fluorescence imaging method. Eyes were also examined by histology, Western analysis, and electroretinography. Subretinal injection of rAAV efficiently delivers inducible genes to both photoreceptors and retinal pigment epithelial cells. GFP expression was initially observed 1 week postinduction, and GFP protein was undetectable after removal of dox. In uninduced animals, GFP expression was negligible. The dox dosage was varied in vivo and showed a correlation to the level of GFP expression. Thus, transduction of retinal cells with tet-inducible vectors allows for tight regulation of gene expression.


Subject(s)
Dependovirus/genetics , Gene Transfer Techniques , Genes, Reporter , Retina/metabolism , Tetracycline/pharmacology , Animals , Blotting, Western , Cell Line , Cloning, Molecular , Dose-Response Relationship, Drug , Electroretinography , Gene Expression Regulation , Genetic Vectors , Green Fluorescent Proteins , Humans , Luminescent Proteins/metabolism , Models, Genetic , Rats , Retinal Degeneration/therapy , Time Factors , Transduction, Genetic
9.
Mol Ther ; 3(4): 507-15, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11319911

ABSTRACT

The goal of these experiments was to evaluate the potential of the fibroblast growth factor family members FGF-5 and FGF-18 to rescue photoreceptors from cell death in retinal degenerative disease. Two strains of transgenic rats, expressing either a P23H or an S334ter rhodopsin mutation, were used as model systems. The neurotrophic growth factors were delivered by subretinal injection of adeno-associated virus vectors, driving expression of the genes with a constitutive CMV promoter. Morphological and functional analyses were performed to determine whether FGF-5 or FGF-18 overexpression could ameliorate cell death in the retina. Immunocytochemistry was used to determine the cellular sites of expression of the factors and to test for up-regulation of FGF receptors due to injection. Significant rescue from photoreceptor cell death was found after injections of vectors expressing either FGF-5 or FGF-18 in the animal models. Increased survival of photoreceptors did not produce a significant increase in electroretinographic responses, however, reflecting either trauma due to the surgery or a suppression of signaling due to expression of proteins. Three weeks after injections, both growth factors were localized to the inner and outer segments of photoreceptors, and the receptors FGFR1 and FGFR2 were also found to be up-regulated in these regions. No visible pathological changes were seen in the FGF-5- or FGF-18-treated eyes. These results indicate that the delivery of either FGF-5 or FGF-18 with adeno-associated virus protects photoreceptors from apoptosis in transgenic rat models of retinitis pigmentosa and that the rescue is probably mediated by conventional receptor tyrosine kinase pathways in photoreceptors.


Subject(s)
Dependovirus/genetics , Fibroblast Growth Factors/genetics , Retinal Degeneration/therapy , Retinitis Pigmentosa/therapy , Animals , Animals, Genetically Modified , Blotting, Western , Cell Death , Cell Line , Cell Survival , Cytomegalovirus/genetics , Disease Models, Animal , Electroretinography , Fibroblast Growth Factor 5 , Genetic Vectors/genetics , Humans , Immunohistochemistry , Models, Genetic , Plasmids/metabolism , Point Mutation , Promoter Regions, Genetic , Rats , Receptor Protein-Tyrosine Kinases/biosynthesis , Receptor Protein-Tyrosine Kinases/genetics , Receptor, Fibroblast Growth Factor, Type 1 , Receptor, Fibroblast Growth Factor, Type 2 , Receptors, Fibroblast Growth Factor/biosynthesis , Receptors, Fibroblast Growth Factor/genetics , Retina/metabolism , Retina/pathology , Retinitis Pigmentosa/genetics , Rhodopsin/genetics , Signal Transduction , Transfection , Up-Regulation
10.
Invest Ophthalmol Vis Sci ; 41(13): 4059-63, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11095595

ABSTRACT

PURPOSE: We previously demonstrated that 350 bp of the human rod cGMP phosphodiesterase beta-subunit (beta-PDE) gene promoter are sufficient to direct high levels of gene expression in human Y-79 retinoblastoma cells in vitro. In this study the cell specificity and expression pattern conferred by the short beta-PDE 5' flanking sequence in vivo were examined. METHODS: A construct containing the bacterial LacZ gene driven by a fragment of the beta-PDE 5' flanking region (-297 to +53) was used to generate transgenic mice. Gene expression was analyzed by measuring beta-galactosidase activity in tissue homogenates or visualizing enzymatic activity or protein production at a cellular level by in situ histochemistry or immunocytochemistry. RESULTS: Three independently derived transgenic lines were generated carrying the -297 to +53 beta-PDE 5' flanking region fragment. Within the retina, the reporter gene was specifically expressed in photoreceptors, consistent with the localization of endogenous beta-PDE. Significant expression of LacZ was not observed in other ocular or peripheral tissues. CONCLUSIONS: Photoreceptor-specific reporter gene expression is driven in vivo by a 350-bp segment of the beta-PDE 5' flanking sequence. This study demonstrates the utility of the human beta-PDE promoter for directing the expression of foreign genes to photoreceptors and suggests that the -297 to +53 beta-PDE 5' flanking region fragment may have important implications for therapeutic gene delivery to the visual cells.


Subject(s)
3',5'-Cyclic-GMP Phosphodiesterases/genetics , Gene Expression , Phosphoric Diester Hydrolases , Photoreceptor Cells, Vertebrate/enzymology , Promoter Regions, Genetic/genetics , 3',5'-Cyclic-GMP Phosphodiesterases/biosynthesis , Animals , Cyclic Nucleotide Phosphodiesterases, Type 6 , DNA Primers/chemistry , Fluorescent Antibody Technique, Indirect , Genes, Reporter/genetics , Lac Operon/genetics , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microscopy, Confocal , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Tissue Distribution , beta-Galactosidase/genetics , beta-Galactosidase/metabolism
11.
Vis Neurosci ; 17(4): 647-55, 2000.
Article in English | MEDLINE | ID: mdl-11016582

ABSTRACT

Although single-channel and whole-cell patch-clamp recordings have demonstrated the presence of Na+ currents in retinal ganglion cell somata, it has not previously been reported that an anti-Na+-channel antiserum stains both retinal ganglion cell somata and proteins with molecular weights corresponding to complexes of alpha and beta subunits. We probed adult goldfish retinas for Na+ channel-like immunoreactivity with a polyclonal antibody directed against the EOIII segment of vertebrate voltage-gated Na+ channels. In vertical sections and whole mounts, this antibody consistently stained the somata, axons, and proximal dendrites of retinal ganglion cells. Some somata in the proximal third of the inner nuclear layer were also stained. In Western blots, this antibody specifically stained multiple protein bands from retina and optic nerve, all with apparent molecular weights between 200 and 315 kDa. The largest of these molecular weights agrees with that reported previously for complexes of alpha and beta subunits in mammalian neurons, including retinal ganglion cells. The intermediate and lowest molecular weights are consistent with the presence of multiple Na+ channel alpha subunits, either in individual proximal retinal neurons or in different morphological subtypes.


Subject(s)
Retinal Ganglion Cells/metabolism , Sodium Channels/metabolism , Animals , Blotting, Western , Dendrites/metabolism , Fluorescent Antibody Technique, Indirect , Frozen Sections , Goldfish , Immunoblotting , Molecular Weight , Optic Nerve/cytology , Optic Nerve/metabolism , Retinal Ganglion Cells/cytology
12.
Proc Natl Acad Sci U S A ; 97(21): 11488-93, 2000 Oct 10.
Article in English | MEDLINE | ID: mdl-11005848

ABSTRACT

Ribozyme-directed cleavage of mutant mRNAs appears to be a potentially effective therapeutic measure for dominantly inherited diseases. We previously demonstrated that two ribozymes targeted to the P23H mutation in rhodopsin slow photoreceptor degeneration in transgenic rats for up to 3 months of age when injected before significant degeneration at postnatal day (P) 15. We now have explored whether ribozyme rescue persists at older ages, and whether ribozymes are effective when injected later in the degeneration after significant photoreceptor cell loss. Recombinant adeno-associated virus (rAAV) vectors incorporating a proximal bovine rod opsin promoter were used to transfer either hairpin or hammerhead ribozyme genes to photoreceptors. For the study of long-term survival, rAAV was administered by subretinal injection at P15, and the rats were allowed to live up to 8 months of age. For the study of late-stage gene transfer, rAAV was administered at P30 or P45, when 40-45% of the photoreceptors already had degenerated. Eyes were examined functionally by the electroretinogram and structurally by morphometric analysis. When injected at P15, expression of either ribozyme markedly slowed the rate of photoreceptor degeneration for at least 8 months and resulted in significantly greater electroretinogram amplitudes at least up to P180. When injected at P30 or P45, virtually the same number of photoreceptors survived at P130 as when injected at P15. Ribozyme rescue appears to be a potentially effective, long-term therapy for autosomal dominant retinal degeneration and is highly effective even when the gene transfer is done after significant photoreceptor cell loss.


Subject(s)
Cell Survival/drug effects , Photoreceptor Cells/drug effects , RNA, Catalytic/pharmacology , Animals , Animals, Genetically Modified , Genetic Therapy , Photoreceptor Cells/cytology , RNA, Catalytic/genetics , RNA, Catalytic/therapeutic use , Rats , Retinal Diseases/genetics , Retinal Diseases/therapy
13.
Invest Ophthalmol Vis Sci ; 41(11): 3622-33, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11006261

ABSTRACT

PURPOSE: We evaluated adeno-associated virus (AAV)-mediated gene transfer of basic fibroblast growth factor (FGF-2) as a therapy for photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa. METHODS: Recombinant adeno-associated virus vector (rAAV) incorporating a constitutive cytomegalovirus (CMV) promoter was used to transfer the bovine FGF-2 gene to photoreceptors. AAV was administered by subretinal injection to transgenic rats (TgN S334ter-4) at postnatal day 15 (P15). Control eyes were uninjected, injected with PBS, or AAV-LacZ. Eyes were examined by histopathology, morphometric analysis, and electroretinography at P60. RESULTS: Expression of recombinant FGF-2 slowed the rate of photoreceptor degeneration. Morphologic studies demonstrated significantly more photoreceptors surviving in eyes injected with AAV-FGF-2 than in controls. Insignificant rescue effects were seen in retinas injected with buffer only. No significant inflammatory response or neovascularization was detected. Electroretinographic (ERG) responses of eyes injected with AAV-FGF-2 were increased compared with uninjected eyes; however, these amplitudes were not significantly larger than eyes receiving an AAV-LacZ control vector. CONCLUSIONS: Transduction of retinal cells with AAV-FGF-2 reduces the rate of photoreceptor degeneration in an S334ter-4 animal model. Despite the lack of significantly increased ERG amplitudes from eyes expressing FGF-2, a greater number of surviving photoreceptors was demonstrated. Delivery of FGF-2 using recombinant AAV has potential as a therapy for retinal degeneration.


Subject(s)
Dependovirus/physiology , Fibroblast Growth Factor 2/therapeutic use , Genetic Therapy/methods , Retinal Degeneration/therapy , Animals , Animals, Genetically Modified , Defective Viruses , Electroretinography , Enzyme-Linked Immunosorbent Assay , Fibroblast Growth Factor 2/metabolism , Fluorescent Antibody Technique, Indirect , Gene Transfer Techniques , Genetic Vectors , Microscopy, Fluorescence , Photoreceptor Cells, Vertebrate/metabolism , Photoreceptor Cells, Vertebrate/pathology , Photoreceptor Cells, Vertebrate/physiology , Photoreceptor Cells, Vertebrate/virology , Rats , Rats, Sprague-Dawley , Retinal Degeneration/metabolism , Retinal Degeneration/pathology , Retinal Degeneration/physiopathology , Reverse Transcriptase Polymerase Chain Reaction
14.
Clin Chem Lab Med ; 38(2): 147-53, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10834402

ABSTRACT

Gene delivery to cells of the retina, particularly to photoreceptor cells, has broad potential both for answering basic questions of retinal biology and for more applied therapeutic purposes. The use of ribozymes as therapy for autosomal dominant retinal diseases is a promising technique, and the theoretical and practical basis for their use is discussed. The process involves designing and testing ribozymes first in vitro and then in animal models of retinal disease. Viral vectors based on the nonpathogenic human adeno-associated virus, when coupled with the strong, rod photoreceptor specific opsin promoter, offer an efficient and nontoxic way to deliver and express ribozymes in photoreceptor cells for long time periods of time. Effective ribozyme-mediated therapy also demands careful in vitro analysis of a ribozyme's ability to efficiently and specifically distinguish between mutant and wild type RNAs. Finally, effective demonstration of therapy in an animal model requires careful analysis of any rescue effect in the retina using multiple criteria, including biochemical, structural and physiological assays. For this purpose, ribozyme therapy in a transgenic rat model of retinitis pigmentosa containing a dominant rod opsin mutation (proline-to-histidine change at position 23) is discussed in detail.


Subject(s)
Genetic Therapy/methods , RNA, Catalytic/genetics , RNA, Catalytic/therapeutic use , Retinitis Pigmentosa/genetics , Retinitis Pigmentosa/therapy , Animals , Animals, Genetically Modified , Base Sequence , Dependovirus/genetics , Genes, Dominant , Genetic Vectors , Humans , Nucleic Acid Conformation , Point Mutation , RNA, Catalytic/chemistry , Rats , Retinitis Pigmentosa/pathology , Rod Opsins/genetics
15.
Invest Ophthalmol Vis Sci ; 41(6): 1546-53, 2000 May.
Article in English | MEDLINE | ID: mdl-10798675

ABSTRACT

PURPOSE: To determine the extent to which rhodopsin mis-sorting and constitutive activation of the phototransduction cascade contribute to retinal degeneration in a transgenic rat model of retinitis pigmentosa. METHODS: Retinas from transgenic rats expressing truncated rhodopsin (Ser334ter) were examined by light and electron microscopic immunocytochemistry at several time points. Retinal degeneration in transgenic rats raised in darkness was evaluated by quantification of outer nuclear layer thickness and by electroretinography. RESULTS: Mutant rhodopsin was found at inappropriately high levels in the plasma membrane and cytoplasm of Ser334ter rat photoreceptors. When the cell death rate was high this mis-sorting was severe, but mis-sorting attenuated greatly at later stages of degeneration, as the cell death rate decreased. The distributions of two other outer segment proteins (the cGMP-gated channel and peripherin) were examined and found to be sorted normally within the photoreceptors of these rats. Raising Ser334ter transgenic rats in darkness resulted in minimal rescue from retinal degeneration. CONCLUSIONS: Because dark rearing Ser334ter rats results in little rescue, it is concluded that constitutive activation of the phototransduction cascade does not contribute significantly to photoreceptor cell death in this rat model. The nature of the rhodopsin sorting defect and the correlation between the severity of mis-sorting and rate of cell death indicate that truncated rhodopsin may cause apoptosis by interfering with normal cellular machinery in the post-Golgi transport pathway or in the plasma membrane.


Subject(s)
Disease Models, Animal , Retinal Rod Photoreceptor Cells/metabolism , Retinitis Pigmentosa/metabolism , Retinitis Pigmentosa/pathology , Rhodopsin/metabolism , Animals , Animals, Genetically Modified , Apoptosis , Biological Transport , Blotting, Western , Electroretinography , Fluorescent Antibody Technique, Indirect , Point Mutation , Rats , Rats, Sprague-Dawley , Retinal Rod Photoreceptor Cells/pathology , Retinitis Pigmentosa/genetics , Rhodopsin/genetics , Vision, Ocular
16.
Nat Med ; 4(8): 967-71, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9701253

ABSTRACT

Ribozymes, catalytic RNA molecules that cleave a complementary mRNA sequence, have potential as therapeutics for dominantly inherited disease. Twelve percent of American patients with the blinding disease autosomal dominant retinitis pigmentosa (ADRP) carry a substitution of histidine for proline at codon 23 (P23H) in their rhodopsin gene, resulting in photoreceptor cell death from the synthesis of the abnormal gene product. Ribozymes can discriminate and catalyze the in vitro destruction of P23H mutant mRNAs from a transgenic rat model of ADRP. Here, we demonstrate that in vivo expression of either a hammerhead or hairpin ribozyme in this rat model considerably slows the rate of photoreceptor degeneration for at least three months. Catalytically inactive control ribozymes had less effect on the retinal degeneration. Intracellular production of ribozymes in photoreceptors was achieved by transduction with a recombinant adeno-associated virus (rAAV) incorporating a rod opsin promoter. Ribozyme-directed cleavage of mutant mRNAs, therefore, may be an effective therapy for ADRP and also may be applicable to other inherited diseases.


Subject(s)
Photoreceptor Cells/pathology , Point Mutation , RNA, Catalytic/metabolism , Retinitis Pigmentosa/genetics , Retinitis Pigmentosa/therapy , Rhodopsin/genetics , Animals , Animals, Genetically Modified , Dependovirus , Disease Models, Animal , Genes, Dominant , Genetic Therapy , Histidine , Proline , Promoter Regions, Genetic , RNA, Catalytic/biosynthesis , RNA, Catalytic/genetics , Rats , Rats, Sprague-Dawley , Retinal Rod Photoreceptor Cells/metabolism , Rhodopsin/metabolism , Rod Opsins/genetics
17.
Proc Natl Acad Sci U S A ; 94(13): 6916-21, 1997 Jun 24.
Article in English | MEDLINE | ID: mdl-9192666

ABSTRACT

We describe a general approach for achieving efficient and cell type-specific expression of exogenous genes in photoreceptor cells of the mammalian retina. Recombinant adeno-associated virus (rAAV) vectors were used to transfer the bacterial lacZ gene or a synthetic green fluorescent protein gene (gfp) to mouse or rat retinas after injection into the subretinal space. Using a proximal murine rod opsin promoter (+86 to -385) to drive expression, reporter gene product was found exclusively in photoreceptors, not in any other retinal cell type or in the adjacent retinal pigment epithelium. GFP-expressing photoreceptors typically encompassed 10-20% of the total retinal area after a single 2-microl injection. Photoreceptors were transduced with nearly 100% efficiency in the region directly surrounding the injection site. We estimate approximately 2.5 million photoreceptors were transduced as a result of the single subretinal inoculation. This level of gene transfer and expression suggests the feasibility of genetic therapy for retinal disease. The gfp-containing rAAV stock was substantially free of both adenovirus and wild-type AAV, as judged by plaque assay and infectious center assay, respectively. Thus, highly purified, helper virus-free rAAV vectors can achieve high-frequency tissue-specific transduction of terminally differentiated, postmitotic photoreceptor cells.


Subject(s)
Dependovirus , Gene Expression , Gene Transfer Techniques , Lac Operon , Photoreceptor Cells , Animals , DNA, Recombinant , Genetic Vectors , Mice , Mice, Inbred C57BL , Rats , Rats, Sprague-Dawley , Retina
18.
Vis Neurosci ; 14(3): 601-8, 1997.
Article in English | MEDLINE | ID: mdl-9194326

ABSTRACT

A class 1 aldehyde dehydrogenase (ALDH) catalyzes oxidation of retinaldehyde to retinoic acid in bovine retina. We used immunocytochemistry and in situ hybridization to localize this enzyme in adult and fetal bovine retinas. Specific ALDH immunoreactivity was present in the cytoplasm of wide-field amacrine cells restricted in distribution to the dorsal part of the adult retina. The somata diameters ranged from approximately 8 microns to approximately 15 microns, and the cells increased in density from approximately 125 cells/mm2 near the horizontal meridian to approximately 425 cells/mm2 in the superior far periphery. The ALDH-positive cells had somata on both sides of the inner plexiform layer (IPL) and processes in two IPL strata. The majority of ALDH-positive cells were unreactive with antibodies against known amacrine cell enzymes and neurotransmitters, including GABA and glycine. The ALDH-positive amacrine cells also did not react with anti-cellular retinoic acid-binding protein, which was present in a subset of GABA-positive amacrine cells. In flat-mounted retinas processed by in situ hybridization, the larger ALDH-positive amacrine cells tended to be more heavily labeled. In addition to amacrine cells, Müller cell processes in the inner retina were weakly immunoreactive for ALDH; however, these glial cells did not contain ALDH mRNA. The pattern of ALDH expression in fetal bovine retinas was documented by immunocytochemistry. No ALDH reactivity was found before 5.5 months; for the remainder of the fetal period, ALDH immunoreactivity was present in amacrine cells similar to those in adult retina. The ALDH-positive amacrine cells in bovine retina are novel, being limited in distribution to the dorsal retina and unlabeled with other amacrine cell-specific markers. Identification of ALDH in amacrine cells provides additional evidence that cells of the inner retina are involved in retinoid metabolism.


Subject(s)
Aging/metabolism , Aldehyde Dehydrogenase/analysis , Neurons/enzymology , Retina/enzymology , Animals , Cattle , Embryonic and Fetal Development/physiology , Immunohistochemistry , In Situ Hybridization , Retina/cytology , Retina/embryology
19.
Proc Natl Acad Sci U S A ; 93(14): 7042-7, 1996 Jul 09.
Article in English | MEDLINE | ID: mdl-8692941

ABSTRACT

Apoptosis of photoreceptors occurs infrequently in adult retina but can be triggered in inherited and environmentally induced retinal degenerations. The protooncogene bcl-2 is known to be a potent regulator of cell survival in neurons. We created lines of transgenic mice overexpressing bcl-2 to test for its ability to increase photoreceptor survival. Bcl-2 increased photoreceptor survival in mice with retinal degeneration caused by a defective opsin or cGMP phosphodiesterase. Overexpression of Bcl-2 in normal photoreceptors also decreased the damaging effects of constant light exposure. Apoptosis was induced in normal photoreceptors by very high levels of bcl-2. We conclude that bcl-2 is an important regulator of photoreceptor cell death in retinal degenerations.


Subject(s)
Apoptosis , Cell Survival , Photoreceptor Cells/metabolism , Photoreceptor Cells/pathology , Proto-Oncogene Proteins/biosynthesis , Proto-Oncogenes , Retinal Degeneration/pathology , Retinal Degeneration/physiopathology , Rod Opsins/biosynthesis , Aging/physiology , Animals , Base Sequence , Crosses, Genetic , DNA Primers , GTP-Binding Proteins/biosynthesis , Humans , Light , Mice , Mice, Inbred BALB C , Mice, Inbred Strains , Mice, Transgenic , Molecular Sequence Data , Polymerase Chain Reaction , Proto-Oncogene Proteins c-bcl-2 , Retinal Degeneration/genetics , Rod Opsins/genetics
20.
Proc Natl Acad Sci U S A ; 89(10): 4422-6, 1992 May 15.
Article in English | MEDLINE | ID: mdl-1350091

ABSTRACT

The beta subunit of the cGMP phosphodiesterase (PDE) gene has been identified as the candidate gene for retinal degeneration in the rd mouse. To study the molecular mechanisms underlying degeneration and the potential for gene repair, we have expressed a functional bovine cGMP PDE beta subunit in transgenic rd mice. One transgenic mouse line showed complete photoreceptor rescue across the entire span of the retina. A second independently derived line showed partial rescue in which photoreceptors in the superior but not the inferior hemisphere of the retina were rescued. In the latter animals, intermediate stages of degeneration were observed in the transition zone between rescued and diseased photoreceptors. Pathologic changes in the retina ranged from vesiculation of the basalmost outer segment discs in otherwise structurally intact rod cells to photoreceptors with highly disorganized outer segments and intact inner segments. Totally or partially rescued retinas showed a corresponding restoration of cGMP PDE activity, whereas nonrescued retinas had minimal enzyme activity, characteristic of the rd phenotype. These transgenic animals provide models for studying the molecular basis of retinal degenerative disease and conclusively demonstrate that the phenotype of rd mice is produced by a defect in the beta subunit of cGMP PDE.


Subject(s)
3',5'-Cyclic-GMP Phosphodiesterases/genetics , Eye Proteins/genetics , Genetic Therapy , Retinal Degeneration/genetics , 3',5'-Cyclic-GMP Phosphodiesterases/metabolism , Animals , Base Sequence , Cattle , Eye Proteins/metabolism , Mice , Mice, Inbred Strains , Mice, Transgenic , Microscopy, Electron , Molecular Sequence Data , Oligodeoxyribonucleotides , Photoreceptor Cells/ultrastructure , Polymerase Chain Reaction/methods , Polymorphism, Restriction Fragment Length , Recombinant Fusion Proteins/metabolism , Retina/cytology , Retina/pathology , Retina/ultrastructure , Retinal Degeneration/therapy , Rod Opsins
SELECTION OF CITATIONS
SEARCH DETAIL
...